首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Study on the consistency of doctor-report outcomes and patient-report outcomes in symptoms of traditional Chinese Medicine: a small sample size trial in diabetics
【24h】

Study on the consistency of doctor-report outcomes and patient-report outcomes in symptoms of traditional Chinese Medicine: a small sample size trial in diabetics

机译:中医症状的医生报告结果和患者报告结果的一致性研究:糖尿病患者的小样本试验

获取原文
           

摘要

Patient-Reported Outcomes (PROs) data are increasingly common and widely accepted in clinical investigations of symptoms. Agreements or differences regarding Doctor-Report Outcomes (DROs) emVS/em PROs data are unclear. In this study, we conducted a clinical trial and investigated the agreement levels of DROs emVS/em PROs in symptoms of diabetics. This study had a parallel self-controlled and double blind design. In total, 90 diabetics who presented with the required symptoms were enrolled in this study, and 83 patients completed the study. The severity (none, mild, moderate, and severe) of each symptom was consistently compared with the Visual Analogue Scale (VAS) for the PROs measure and the numerical rating scales (NRS) for the DROs measure. The Kappa index was used to test the agreement in the variables. Our results show that most of the agreements regarding DROs emVS/em PROs were moderate; few were modest and substantial. However, the DROs data failed to agree with the PROs data well in which symptoms effective evaluation criteria overlapped with the inclusion criteria. We believe this results are caused by distortion of information during the doctor’s decision process. We suggest that the effective evaluation criteria should not be overlapped with the inclusion criteria in the DROs design. And if it is unavoidable, PROs design should be worth considering.
机译:患者报告的结果(PRO)数据越来越普遍,并且在症状的临床研究中被广泛接受。关于医生报告结果(DRO) VS PRO数据的协议或差异尚不清楚。在这项研究中,我们进行了一项临床试验,并研究了糖尿病症状中DROs VS PROs的一致水平。这项研究具有平行的自我控制和双盲设计。共有90名出现所需症状的糖尿病患者参加了这项研究,共有83名患者完成了这项研究。将每种症状的严重程度(无,轻度,中度和重度)与PRO量度的视觉模拟量表(VAS)和DRO量度的数字评分量表(NRS)进行比较。 Kappa索引用于测试变量中的一致性。我们的结果表明,大多数关于DRO VS PRO的协议都是中等的;很少有谦虚和充实。但是,DROs数据与PROs数据不一致,后者的症状有效评估标准与纳入标准重叠。我们认为,此结果是由医生决策过程中的信息失真引起的。我们建议有效的评估标准不应与DRO设计中的纳入标准重叠。并且如果不可避免,那么PRO设计应该值得考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号